For hospital pharmacy committees, clinic procurement teams and pharmacies, seasonal influenza vaccines are a time-bound purchase: strain compositions are reviewed by WHO each year, batches are cold-chain sensitive, and stock planning has to be done before the season starts. This article reports what the manufacturer labels, WHO advisories and Indian bodies publish on quadrivalent influenza vaccines, written for institutional buyers and clinicians. It is informational reporting, not clinical guidance.